<DOC>
	<DOCNO>NCT00006468</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know regimen combination chemotherapy effective metastatic colorectal cancer . PURPOSE : Randomized phase III trial compare effectiveness two combination chemotherapy regimens treat patient metastatic colorectal cancer .</brief_summary>
	<brief_title>Comparing Two Combination Chemotherapy Regimens Treating Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy intermittent high-dose oxaliplatin combination simplify bimonthly regimen leucovorin calcium ( LV ) fluorouracil ( 5-FU ) v standard dose oxaliplatin combination standard bimonthly regimen LV 5-FU patient metastatic colorectal cancer . - Determine time treatment failure , tolerance , response rate , overall survival patient treat 2 regimen . - Compare quality life patient treat regimen . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord treatment center , performance status ( 0-1 v 2 ) , number metastatic site ( 1 vs 1 ) . Patients randomize one two treatment arm . - Arm I : Patients receive oxaliplatin IV 2 hour day 1 , leucovorin calcium IV 2 hour follow fluorouracil ( 5-FU ) IV 22 hour day 1 2 . - Arm II : Patients receive oxaliplatin IV leucovorin calcium IV 2 hour follow 5-FU IV 46 hour begin day 1 course 1-6 19-24 . For course 7-18 , patient receive leucovorin calcium IV follow 5-FU IV begin day 1 . Courses repeat every 14 day arm absence disease progression unacceptable toxicity . Quality life assess baseline , course 4 6 , every 6 course thereafter . Patients follow monthly 3 month every 3 month thereafter . PROJECTED ACCRUAL : A total 460 patient ( 230 per treatment arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unresectable metastatic adenocarcinoma colon rectum Bidimensionally measurable evaluable disease outside previously irradiate area No bone metastasis target lesion At least 1 cm spiral CT scan OR At least 2 cm conventional CT scan No CNS metastasis No symptomatic ascites pleural effusion evacuate No total partial bowel obstruction PATIENT CHARACTERISTICS : Age : 18 80 Performance status : ECOG 02 WHO 02 Life expectancy : Not specify Hematopoietic : Neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Alkaline phosphatase less 5 time upper limit normal ( ULN ) Renal : Creatinine le 3 time ULN No uncontrolled hypercalcemia Cardiovascular : No uncontrolled congestive heart failure , angina pectoris , hypertension , arrhythmias Other : No peripheral sensory neuropathy No prior significant neurologic psychiatric disorder No malignancy within past 5 year except adequately treat carcinoma situ cervix basal squamous cell skin carcinoma No active infection No concurrent serious disease Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy metastatic disease Chemotherapy : Prior adjuvant chemotherapy allow , provide progressionfree interval 6 month since end last course No prior oxaliplatin irinotecan No prior chemotherapy metastatic disease No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No concurrent radiotherapy Surgery : Concurrent surgery allow Other : At least 30 day since prior investigational drug No concurrent investigational treatment No concurrent antitumoral treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2000</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>